Three organizational capabilities industry leaders will need to help navigate the business challenges caused by COVID-19
Life Sciences
Accelerating digitization with deep industry expertise
As life sciences organizations work to minimize regulatory and competitive impacts and maximize revenue potential, CGI offers expertise and solutions to help them reinvent ways of working. We assist pharma, biotech and medical device companies in achieving their goals, from early stage development, to data capture, to regulatory submission and even late stage development.
Annually,
CGI
leaders
around
the
world
meet
face-to-face
with
business
and
IT
executives
to
gather
their
perspectives
on
the
trends
affecting
their
enterprises,
including
business
and
IT
priorities,
IT
spending,
budgets
and
investment
plans.
In
2020,
we
conducted
in-person
interviews
...
CGI expertise and services help life sciences organizations increase speed, efficiency and innovation, while keeping pace with compliance demands. Key capabilities include:
-
Commercial launch and operations to simplify planning and execution and improve launch efficiency
-
Clinical services to reduce the duration of drug development timelines
-
Manufacturing innovation to achieve end-to-end supply chain optimization, manufacturing execution excellence, transport management and ERP, including Industry 4.0
-
Regulatory compliance to help clients continuously monitor clinical drug safety data across the entire product life cycle
-
Outsourcing to improve the management and operation of company-wide infrastructures, application suites and business processes
-
Intelligent automation to increase efficiency of operations by combining advanced analytics with IoT and AI for predictive maintenance
Explore enabling technologies
CGI solutions and services also have supported:
-
For an international Swiss pharmaceutical company, data cleansing as a part of data migration process
-
For an international pharmaceutical company, bringing product to market faster and more effectively through design, implementation and maintenance of an integrated clinical portfolio framework and architecture
-
For a global pharmaceutical company headquartered in Germany, maintenance and development of a risk management tool, knowledge management application and software solution to manage biological entities
Case studies
Related media
As
the
COVID-19
pandemic
rapidly
spread
across
the
globe
in
the
early
months
of
2020,
the
Montreal
Heart
Institute
(MHI)
responded
by
launching
a
major
clinical
study
to
test
a
...
In
2019,
as
presented
in
our
CGI
Client
Global
Insights,
we
spoke
in
person
with
more
than
1,550
executives
across
10
industries
to
gather
their
perspectives
on
the
trends
affecting
...
In
2019,
we
conducted
in-person
interviews
with
96
client
executives
in
health
and
life
sciences
who
cite
becoming
a
digital
organization
to
meet
patient
and
customer
expectations
is
top
of
...